Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

PHASE3RecruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2026

Conditions
Social Anxiety Disorder (SAD)
Interventions
DRUG

Fasedienol Nasal Spray

Nasal spray delivered 20 minutes before the PSC

DRUG

Placebo Nasal Spray

Nasal spray delivered 20 minutes before the PSC

Trial Locations (21)

30030

RECRUITING

Vistagen Clinical Site, Decatur

33629

RECRUITING

Vistagen Clinical Site, Tampa

39232

RECRUITING

Vistagen Clinical Site, Flowood

45229

TERMINATED

Vistagen Clinical Site, Cincinnati

48302

RECRUITING

Vistagen Clinical Site, Bloomfield Township

60563

RECRUITING

Vistagen Clinical Site, Naperville

60640

RECRUITING

Vistagen Clinical Site, Chicago

72211

ACTIVE_NOT_RECRUITING

Vistagen Clinical Site, Little Rock

75251

RECRUITING

Vistagen Clinical Site, Dallas

77055

RECRUITING

Vistagen Clinical Site, Houston

78229

RECRUITING

Vistagen Clinical Site, San Antonio

78737

RECRUITING

Vistagen Clinical Site, Austin

78759

RECRUITING

Vistagen Clinical Site, Austin

80209

ACTIVE_NOT_RECRUITING

Vistagen Clinical Site, Denver

87109

RECRUITING

Vistagen Clinical Site, Albuquerque

89119

ACTIVE_NOT_RECRUITING

Vistagen Clinical Site, Las Vegas

89121

TERMINATED

Vistagen Clinical Site, Las Vegas

90504

RECRUITING

Vistagen Clinical Site, Torrance

90706

RECRUITING

Vistagen Clinical Site, Bellflower

92374

RECRUITING

Vistagen Clinical Site, Redlands

92868

RECRUITING

Vistagen Clinical Site, Orange

All Listed Sponsors
lead

VistaGen Therapeutics, Inc.

INDUSTRY